These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27732643)
21. Chemical genetics and drug discovery in Xenopus. Tomlinson ML; Hendry AE; Wheeler GN Methods Mol Biol; 2012; 917():155-66. PubMed ID: 22956087 [TBL] [Abstract][Full Text] [Related]
22. High Content, Phenotypic Assays and Screens for Compounds Modulating Cellular Processes in Primary Neurons. Kepiro M; Varkuti BH; Davis RL Methods Enzymol; 2018; 610():219-250. PubMed ID: 30390800 [TBL] [Abstract][Full Text] [Related]
23. High content screening for modulators of cardiovascular or global developmental pathways in zebrafish. Williams CH; Hong CC Methods Mol Biol; 2015; 1263():167-74. PubMed ID: 25618344 [TBL] [Abstract][Full Text] [Related]
24. A zebrafish (danio rerio) model for high-throughput screening food and drugs with uric acid-lowering activity. Zhang Y; Li Q; Wang F; Xing C Biochem Biophys Res Commun; 2019 Jan; 508(2):494-498. PubMed ID: 30503500 [TBL] [Abstract][Full Text] [Related]
25. The zebrafish: a powerful platform for in vivo, HTS drug discovery. Delvecchio C; Tiefenbach J; Krause HM Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713 [TBL] [Abstract][Full Text] [Related]
27. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries. Lessman CA Birth Defects Res C Embryo Today; 2011 Sep; 93(3):268-80. PubMed ID: 21932435 [TBL] [Abstract][Full Text] [Related]
28. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives. Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799 [TBL] [Abstract][Full Text] [Related]
29. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data. Paricharak S; IJzerman AP; Bender A; Nigsch F ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899 [TBL] [Abstract][Full Text] [Related]
32. Epigenetic assays for chemical biology and drug discovery. Gul S Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316 [TBL] [Abstract][Full Text] [Related]
33. In vivo Imaging of Fully Active Brain Tissue in Awake Zebrafish Larvae and Juveniles by Skull and Skin Removal. Schramm P; Hetsch F; Meier JC; Köster RW J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645565 [TBL] [Abstract][Full Text] [Related]
35. Whole-organism screening for modulators of fasting metabolism using transgenic zebrafish. Gut P; Stainier DY Methods Mol Biol; 2015; 1263():157-65. PubMed ID: 25618343 [TBL] [Abstract][Full Text] [Related]
36. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. Winter MJ; Redfern WS; Hayfield AJ; Owen SF; Valentin JP; Hutchinson TH J Pharmacol Toxicol Methods; 2008; 57(3):176-87. PubMed ID: 18337127 [TBL] [Abstract][Full Text] [Related]
37. Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds. Ritler D; Rufener R; Sager H; Bouvier J; Hemphill A; Lundström-Stadelmann B PLoS Negl Trop Dis; 2017 May; 11(5):e0005618. PubMed ID: 28520724 [TBL] [Abstract][Full Text] [Related]
38. Delayed effects of methylmercury on the mitochondria of dopaminergic neurons and developmental toxicity in zebrafish larvae (Danio rerio). Huang SS; Noble S; Godoy R; Ekker M; Chan HM Aquat Toxicol; 2016 Jun; 175():73-80. PubMed ID: 26994370 [TBL] [Abstract][Full Text] [Related]